Drug Litigation May 1, 2026 · 9 min read

Do You Qualify for the Ozempic Lawsuit? 2026 Eligibility Guide

Tens of thousands of patients who used Ozempic, Wegovy, Mounjaro, or related GLP-1 drugs have suffered serious side effects including gastroparesis, pancreatitis, gallbladder disease, and intestinal obstruction. Not every adverse reaction supports a lawsuit — here is what you need to meet the eligibility criteria for an Ozempic-related legal claim.

Qualifying Medical Conditions

The strongest Ozempic and GLP-1 lawsuits involve serious, documented conditions including gastroparesis (stomach paralysis diagnosed with a gastric emptying study), acute pancreatitis or chronic pancreatitis, gallbladder disease requiring surgical removal, intestinal obstruction or ileus, and severe aspiration events. Some lawsuits also involve vision loss — cases of nonarteritic anterior ischemic optic neuropathy (NAION) linked to GLP-1 use. Not all nausea and vomiting rises to the level required for a claim — the condition must be serious enough to require medical treatment or hospitalization.

Gastroparesis confirmed by gastric emptying study
Acute pancreatitis requiring hospitalization
Gallbladder disease/cholecystitis requiring surgery
Intestinal blockage or ileus
Severe aspiration pneumonia from vomiting while sedated
Vision changes or loss (NAION)

Drug and Dosage Criteria

The lawsuits primarily target Novo Nordisk's semaglutide products (Ozempic for diabetes, Wegovy for weight loss) and Eli Lilly's tirzepatide products (Mounjaro for diabetes, Zepbound for weight loss). Other GLP-1 agonists including Victoza (liraglutide), Trulicity (dulaglutide), and Byetta (exenatide) may also be relevant. The length of use matters: brief use of a few weeks is typically not sufficient; claims are stronger when the drug was used for at least several months before symptoms developed.

Suffered serious side effects from Ozempic or Wegovy?

Find out if you may qualify — free case review.

Check Eligibility arrow_forward

Timeline Requirements

To qualify, you generally need to show that you used a GLP-1 drug, then developed a qualifying condition during or after that use. The causal sequence — drug first, then illness — is essential. If you had pre-existing gastroparesis or pancreatitis before starting Ozempic, your claim is more complex but may still be viable if the drug dramatically worsened your pre-existing condition. Statutes of limitations vary by state but typically run two to three years from the date of diagnosis or from when you reasonably should have connected your condition to the drug.

How to Evaluate Your Claim

The fastest way to determine eligibility is a free case evaluation with a drug injury attorney experienced in GLP-1 litigation. Gather your prescription records showing which drug you used, when you started, and your dosage; your medical records documenting your diagnosis; and records of any hospitalizations related to your condition. Most GLP-1 attorneys take cases on contingency, meaning no fees unless you recover.

Frequently Asked Questions

I only used Ozempic for a few weeks before I got sick. Does that count?expand_more

It depends. A very short exposure period weakens the causal argument. However, if you developed acute pancreatitis or a severe event very shortly after starting Ozempic, there may be a temporal link strong enough to support a claim. An attorney can evaluate the specific circumstances.

My doctor prescribed Ozempic off-label for weight loss. Does that affect my claim?expand_more

No. If a physician prescribed Ozempic for weight loss (rather than its FDA-approved indication of type 2 diabetes), Novo Nordisk's duty to warn about serious risks still applies. The off-label use does not release the manufacturer from liability for known but undisclosed risks.

Can I file an Ozempic claim if I also have type 2 diabetes?expand_more

Yes. Many Ozempic users have type 2 diabetes — that is the drug's primary indication. Your diabetes does not disqualify your claim. Attorneys and experts will assess whether your specific condition (such as gastroparesis or pancreatitis) was more likely caused by the drug than by underlying diabetes complications.

edit_note

SuperLawsuits Editorial Team

Reviewed by licensed attorneys in our network